Daniel J. Curran - 20 Nov 2025 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ Daniel J. Curran
Issuer symbol
CPRX
Transactions as of
20 Nov 2025
Transactions value $
$0
Form type
4
Filing time
24 Nov 2025, 20:08:19 UTC
Previous filing
13 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Curran Daniel J. Director 355 ALHAMBRA CIRCLE, SUITE 801, CORAL GABLES /s/ Daniel J. Curran 24 Nov 2025 0001887599

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Award $0 +18.1K +45.29% $0.00 58.1K 20 Nov 2025 Common Stock 18.1K $22.77 Direct F1
transaction CPRX Restricted Stock Units Award $0 +5.47K +9.41% $0.00 63.6K 20 Nov 2025 Common Stock 5.47K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Derivative securities vest in equal tranches, 1/3rd on November 20, 2026, 1/3rd on November 20, 2027 and 1/3rd on November 20, 2028.
F2 Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
F3 Shares of common stock will be delivered to the Reporting Person upon vesting.